Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin

Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin

<b>Background</b>: Obesity and type 2 diabetes mellitus (T2DM) are characterized by underlying low-grade chronic inflammation. Metformin has been used as the first line of therapy in T2DM as it decreases hepatic glucose production and glucose intestinal absorption, enhances insulin sensi...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Awad Alshahrani, Ahmad Aljada, Afshan Masood, Muhammad Mujammami, Assim A. Alfadda, Mohthash Musambil, Ibrahim O. Alanazi, Mohammed Al Dubayee, Anas M. Abdel Rahman, Hicham Benabdelkamel
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: MDPI AG 2023-09-01
Ráidu:Pharmaceuticals
Fáttát:
metformin
proteomics
obesity
type 2 diabetes mellitus
mass spectrometry
Liŋkkat:https://www.mdpi.com/1424-8247/16/10/1345

Interneahtta

https://www.mdpi.com/1424-8247/16/10/1345

Geahča maid